Blue Dart to offer supply chain solutions for vaccine transportations

News Clip: Live Mint

6th October, 2020

Logistics services provider Blue Dart on Tuesday said it will offer a complete supply chain solution for the life sciences and clinical trials sector and reefer vehicles (cold chain) services, to ensure seamless transport of shipments like vaccines. The firm, which is a part of the Deutsche Post DHL Group (DPDHL), has capability to handle various temperature requirements. As the development of the COVID-19 vaccine leapfrogs across development phases, stringent temperature requirements (up to - 80°C) will be a critical factor for its transportation and warehousing at every stage, Blue Dart said in a release.

Stating that an efficient and specialized logistics network will be a prerequisite, to ensure safe and rapid delivery of billions of COVID-19 vaccine doses for mass immunization, and other temperature sensitive pharma products on a national and global scale, the company said, "It is ramping up its infrastructure with its pre-existing specialized Temperature Controlled Logistics (TCL) to combat the pandemic".